Australian shares rose on Tuesday on positive news from another coronavirus vaccine trial, and equity market operations resumed without incident after a software glitch forced the exchange operator to halt trade in the previous session.

Australian shares were set to open flat on Tuesday, shrugging off optimism over progress towards a COVID-19 vaccine, with investors likely to remain wary after trading was halted due to a data glitch in the previous session. Trading on Australia's stock excha…

The S&P 500 and Dow Jones industrial average notched record closing highs on Monday as news of another promising coronavirus vaccine fanned hopes of eradicating COVID-19, while spiking infections and new shutdowns threatened to hobble a recovery from the pand…

Summary List PlacementOn Monday morning, Moderna announced success in its experimental coronavirus vaccine results. According to the firm, its vaccine had a 94.5% effective rate. Pharmaceutical giant Pfizer announced their vaccine's success a week before Mode…

The announcement closely follows similar news from a rival Pfizer and BioNTech vaccine program, which touted success in the last stage a week ago.

The widespread distribution of vaccines to combat the coronavirus pandemic and ongoing monetary easing could cause the U.S. dollar to weaken as much as 20% next year, Citibank said on Monday.

The widespread distribution of vaccines to combat the coronavirus pandemic and ongoing monetary easing could cause the U.S. dollar <=USD> to weaken as much as 20% next year, Citibank said on Monday.

Canada's main stock index rose on Monday, as energy stocks jumped 3% tracking oil prices, after U.S. drugmaker Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19.

Canada's main stock index opened higher on Monday, helped by a 4.7% jump in energy stocks as oil prices gained after Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19.

Wall Street's main indexes opened higher on Monday after Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19, boosting hopes of the economy emerging from a year of pandemic-induced downturn.

Global stocks eyed a fresh record high on Monday as signs of economic recovery in Asia, strong corporate earnings and additional positive data about a COVID-19 vaccine boosted investor sentiment.

My second shot in the Moderna COVID vaccine trial gave me muscle stiffness and a short-term fever. So I think I got the real vaccine, not a placebo.

Futures tracking the S&P 500 and the Dow rose on Monday after Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19, a week after Pfizer Inc reported positive results from its own late-stage trial.

Japanese stocks touched a 29-year high on Monday after the economy posted its first expansion in four quarters and as progress in developing a COVID-19 vaccine continued to lift global markets.

Japanese stocks touched a 29-year high on Monday after the economy posted its first expansion in four quarters and as progress in developing a COVID-19 vaccine continued to lift global markets.

Asia's stock markets opened higher on Monday, as vaccine optimism offset worries about rising coronavirus cases in Europe and new lockdowns in the United States, while oil prices and risk-exposed currencies also edged higher.

Asia's stock markets opened higher on Monday, as vaccine optimism offset worries about rising coronavirus cases in Europe and new lockdowns in the United States, while oil prices and risk-exposed currencies also edged higher.

Asia's stock markets opened higher on Monday, as vaccine optimism offset worries about rising coronavirus cases in Europe and new lockdowns in the United States, while oil prices and risk-exposed currencies also edged higher.

Asia's stock markets opened higher on Monday, as vaccine optimism offset worries about rising coronavirus cases in Europe and new lockdowns in the United States, while oil prices and risk-exposed currencies also edged higher.

Asian shares rose toward a more than two-year peak on Thursday, buoyed by sustained global stimulus efforts and hopes of a coronavirus vaccine, but some analysts warned of the risk of a correction lower.

Asian shares pared their gains in choppy trade on Thursday as investors awaited further details on whether drugmakers can develop a coronavirus vaccine.

Switzerland now has reserved around 16 million doses of potential COVID-19 vaccines, the government said on Wednesday, after announcing a 3.2 million-dose reservation with a World Health Organization-led program and another 3 million-dose pact with Pfizer and…

Shares of Moderna Inc rose 11% on Wednesday after the company signed a $1.5 billion deal with the U.S. government for the supply of its experimental coronavirus vaccine.

Australia recorded its deadliest day of the coronavirus pandemic on Wednesday, while New Zealand reimposed restrictions as it investigates its first cases in more than three months.

$MRNA - Is Moderna Stock A Buy As It Doubles Down On Its Cancer Vaccine Efforts? https://t.co/0cdMY69lBb

RT @visionary_nft: @blknoiz06 I would never buy the stock but under the circumstances I took the trade. I don’t regret it morally I was lo…

No coincidence. Bill Gates and the Gates Foundation were forcing Covid vaccines and the narrative on the world with media and WHO funding. Gates profited off this with Moderna stock. Gates needs investigated and imprisoned. @GOPoversight @DOJPH If you don’t, we will. https://t.co/G1od20mtgd

$MRNA was this quarter's top loser, falling -18.9% #Moderna #stockmarket #stock https://t.co/UodFBed82s

RT @Tentoads4truth: Add/Moderna Co-Founder Noubar Afeyan Sells Large Blocks of Stock https://t.co/wx0dh5NJQB

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

RT @FrankGrimes_Jr: The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were re…

The CEO of Moderna has been dumping stock since December 2021. When vaccines were mandated and ongoing boosters were required you'd think he would want to hold onto his stock. Instead he's dumping it. He's now selling $4,700,000 a week! https://t.co/NM7WjRyIsw

Funny how Bill Gates who became a billionaire by creating computer viruses so his company could sell virus protection programs… is now in the creating human viruses business. He and Moderna ( probably owns all their stock ) are still trying to milk the corona scam. BOO Anh !!!… https://t.co/S0yk36765U

Steve Weiss, who predicted a 500% rise in Moderna's stock, is now selling a large portion of his position as the CEO also dumps shares. The stock has fallen 75% since its peak. #Moderna #MRNA #negative https://t.co/m3vXMO1W8L

Steve Weiss, who predicted a 500% rise in Moderna's stock, is now selling a large portion of his position as the CEO also dumps shares. The stock has fallen 75% since its peak. #Moderna #MRNA #negative https://t.co/jmuenizMug

Steve Weiss, who predicted a 500% rise in Moderna's stock, is now selling a large portion of his position as the CEO also dumps shares. The stock has fallen 75% since its peak. #Moderna #MRNA #negative https://t.co/hWG5gJfxQ5

Moderna Requests FDA Approval of Updated Covid Vaccine #pennystocks #wallstreet #marketing #digitalmarketing #emergingmarkets #venturecapital #finance #ir #financenews #streetwiseir #invest #investing #investor #investornews #stock #stocks https://t.co/RL3P241EeN

Moderna Requests FDA Approval of Updated Covid Vaccine #pennystocks #wallstreet #marketing #digitalmarketing #emergingmarkets #venturecapital #finance #ir #financenews #streetwiseir #invest #investing #investor #investornews #stock #stocks https://t.co/pKJ1r8HJGc

Just because a company is undervalued, it certainly doesn't mean its stock price will rise. Moderna has major problems, namely a huge decrease in demand every year Unless Covid mutates into a superbug, I think decreasing demand will weigh on it heavily https://t.co/bjESz3EYdD

$MRNA $UBS - Moderna stock price forecast: UBS sees a 60% upside https://t.co/iG9NEO5wtW

Moderna stock price forecast: UBS sees a 60% upside - https://t.co/0habLgqVL3

$MRNA - Moderna Stock Upgrade Has Call Traders Moving In https://t.co/1B1VkXRinT

Moderna Stock Rises After FDA Application For Updated Vaccine https://t.co/rSn7xceBTe

$MRNA CEO Stephan Bancel has been selling shares like there’s no tomorrow! About $5 Million worth of stock a week recently #moderna #InsiderSelling https://t.co/aw4ibOICjz https://t.co/fSh2SWIDjS

Moderna stock gained following an upgrade by UBS to buy! The bank said "stock’s current valuation" is not pricing upside from other vaccines! $MRNA #pharma #vaccine https://t.co/N16fQoR9bI https://t.co/YpKTaD68wj

$MRNA is a 'B'uy? Who still uses the B word? "Moderna Stock Is a Buy. The Pipeline Is Underappreciated, Says Analyst." @UBS https://t.co/SR56cvIdZ2

UBS analyst Eliana Merle upgraded Moderna stock to Buy from Neutral, but trimmed the price target. The Covid and RSV businesses alone are worth $123 a share, she says. https://t.co/PeyfmwdbuN

I could never own a stock this evil Nor Moderna https://t.co/N59fasgvLF

Lucid, Tesla $TSLA, PacWest, Moderna, Wolfspeed, and More Stock Market #StockMarket Movers - Barron's https://t.co/FsVVelPEhF https://t.co/dPBPyuEAbV

Lucid, Tesla, PacWest, Moderna, Wolfspeed and more stock markets https://t.co/NhdhQyeLgQ

RT @dougbrownDBA: Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In? #Business #Startup #Success https://t…

A.I.dvisor made a bearish call on $MRNA, netting in a 5.66% gain over 2 weeks #Moderna #stockmarket #stock https://t.co/UXlN0686bG https://t.co/V6ioWsADEQ

RT @JohnWest_JAWS: Hmm.. Interesting that the decision to axe Valverna (at a £358m cost to taxpayer) and instead award the contract to Mod…

RT @JohnWest_JAWS: Hmm.. Interesting that the decision to axe Valverna (at a £358m cost to taxpayer) and instead award the contract to Mod…

RT @JohnWest_JAWS: Hmm.. Interesting that the decision to axe Valverna (at a £358m cost to taxpayer) and instead award the contract to Mod…